Researchers in the Faculty of Medicine collaborate with colleagues in other departments and 911½ñÈÕºÚÁÏ faculties and partner with leading external institutes to expand the possibilities of our science and drive multidisciplinary opportunities to solve real world challenges. 

Multidisciplinary research at 911½ñÈÕºÚÁÏ is supported through our cross-College Networks, Institutes and Centres of Excellence. 

Below are some of the key external academic partners that play a vital role in the collaborative life of our Faculty.

Academic Partners

MRC Laboratory of Medical Sciences

Hosted in the heart of our Hammersmith Hospital Campus, the MRC Laboratory of Medical Sciences (LMS) is an interdisciplinary research institute where scientists and clinicians collaborate to advance the understanding of biology and its application to medicine. Co-location with the hospital, the Faculty of Medicine and proximity to the 911½ñÈÕºÚÁÏ’s life sciences hub and innovation district in White City enables their research to be underpinned by translation, clinical impact and training the next generation of leading clinical and non-clinical scientists.  

Francis Crick Institute

The (established 2010, formally opened 2016) is a biomedical research institute which breaks down barriers between disciplines allowing bold ideas to be pursued. The Crick is a unique partnership between six world leading biomedical research organisations: the , , , 911½ñÈÕºÚÁÏ,  a²Ô»å . Our partnership with the Crick provides our academic community with a wealth of opportunities for high calibre collaborative research to understand how living things work and to drive benefits for human health. 

Rosalind Franklin Institute

The is a national research institute dedicated to developing new technologies to tackle important health research challenges. 911½ñÈÕºÚÁÏ is one of the ten university partners across the UK who founded the Institute. Individually extraordinary, the combination of tools under development at the Franklin’s Hub will yield new imaging, interpretation and intervention in biological systems leading the development tomorrow’s healthcare innovations. 

partnerships2

Institute of Cancer Research

The Institute of Cancer Research, London (ICR) is one of the world’s most influential cancer research institutes, with an outstanding track record dating back more than 100 years. Together with IICR, 911½ñÈÕºÚÁÏ has established the Cancer Research UK (CRUK) Convergence Science Centre and the Cancer Epidemiology Prevention Research Unit (CEPRU). The aims to develop innovative solutions for cancer prevention, diagnosis and treatment by combining engineering, physical sciences, life sciences with medicine. CEPRU aims to be a global leader in advancing research to understand the cancer continuum, from causes to clinical outcomes,  translating this into effective strategies for cancer prevention and early detection.  

UK DRI

911½ñÈÕºÚÁÏ is one of the six founding members of the (UK DRI), a national initiative to combat dementia. The Institute aims to transform treatment and care for people with dementia, through cutting-edge research in its seven centres located across the UK,  bringing people together for shared scientific inspiration, whilst making the most of cutting-edge tools and infrastructure locally. 911½ñÈÕºÚÁÏ is home to two centres The UK DRI Centre at 911½ñÈÕºÚÁÏ focuses on the earliest stages of dementia and the influences of the body, environment and lifestyle on the brain. while the UK DRI Care Research & Technology Centre, aims to empower people with dementia and their caregivers by creating dementia-friendly ‘Healthy Homes’ – intelligent environments that transform and personalise care. 

The George Institute for Global Health UK

The George Institute is a leading independent global medical research institute with major centres in Australia, China, India and the UK. In 2020, The George Institute partnered with 911½ñÈÕºÚÁÏ to establish the on our White City Campus to pursue world-class research in health systems, women’s health, and multimorbidity as well as conducting large-scale clinical trials and tackling planetary health issues.  With a focus on low- and middle- income countries and under-served communities in high income countries, our research supports progress towards universal health coverage and sustainable development.